NeuroDigiTech
Private Company
Funding information not available
Overview
NeuroDigiTech is a specialized neuroscience CRO and product vendor founded in 2020, operating from San Francisco. The company combines traditional neurohistology services with proprietary staining kits and AI-driven digital imaging and morphometric analysis to serve academic and biopharma clients in preclinical CNS drug development. Its core value proposition is providing time- and cost-effective, high-quality data generation and analysis for complex brain studies, with a particular focus on neurodegenerative diseases. NDT operates through a hybrid business model of fee-for-service work and product sales.
Technology Platform
Integrated platform combining proprietary neural staining chemistry (e.g., GolgiChrome™ kit), high-throughput digital microscopy, and AI/unbiased stereology-based morphometric analysis for quantitative preclinical CNS research.
Opportunities
Risk Factors
Competitive Landscape
NDT competes with large, full-service CROs (e.g., Charles River, Labcorp) that have neuroscience departments, other specialized neuro-CROs, and life science tools companies selling histological stains and antibodies. Its differentiation lies in its exclusive CNS focus, proprietary staining kits (especially GolgiChrome™), and integrated offering of wet-lab services with advanced digital morphometrics.